 |
|
Immune Function and Vaccine Responses in Healthy Advanced Elderly Patients
Paul J. Carson, MD;
Kristin L. Nichol, MD;
James O'Brien;
Pierre Hilo;
Edward N. Janoff, MD
Arch Intern Med. 2000;160:2017-2024.
Background Decline in immune function has been reported to predictably accompany advancing age. However, to our knowledge, few studies have specifically characterized the rapidly expanding advanced elderly population or controlled adequately for concurrent diseases.
Objective To assess whether successfully reaching an advanced age in good health is associated with preserved immune function.
Methods We prospectively compared in vivo with in vitro variables of immune function in 29 healthy, independently living elderly subjects (mean age, 80 years; age range, 75-103 years) and in 21 healthy young control subjects (mean age, 29 years; age range, 25-35 years) in a Veterans Affairs Medical Center.
Results In vivo, among elderly and young subjects, numbers of total white blood cells, monocytes, lymphocytes, and lymphocyte subsets (CD4+ and CD8+ T lymphocytes and CD20+ B cells) were similar, as were levels of total serum IgG and IgM. Only levels of serum IgA were higher in the elderly subjects (3.0 vs 1.7 g/L; P=.001). Functionally, both groups showed vigorous responses to protein (tetanus and diphtheria toxoids) and polysaccharide (23-valent pneumococcal) vaccines. Although levels varied, the fold increases in vaccine antigen-specific IgG were not significantly different in young and elderly subjects, and the avidities of IgG to pneumococcal polysaccharides 14 and 19F were similar before and after vaccination. In vitro, proliferative responses of blood mononuclear cells to T-lymphocyte and B-cell mitogens (pokeweed mitogen, Staphylococcus aureus Cowan strain I, and S aureus Cowan strain I plus interleukin 2), and lipopolysaccharide-induced production of tumor necrosis factor  , were comparable in elderly vs young subjects.
Conclusion Successful aging, defined by reaching an advanced age with one's overall health intact, may be associated with preserved immune function and adequate responses to vaccines.
From the Infectious Disease Section (Drs Carson and Janoff and Messrs O'Brien and Hilo) and the Medicine Service (Dr Nichol), Department of Medicine, and the Mucosal and Vaccine Research Center (Drs Carson, Nichol, and Janoff and Messrs O'Brien and Hilo), Veterans Affairs Medical Center, University of Minnesota School of Medicine, Minneapolis. Dr Carson is now with MeritCare Health System, Fargo, ND; and Messrs O'Brien and Hilo are now with the Research Service, Veterans Affairs Medical Center, University of Minnesota School of Medicine.
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(13):2068-2069.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Guidelines for the management of adult lower respiratory tract infections
Woodhead et al.
Eur Respir J 2005;26:1138-1180.
ABSTRACT
| FULL TEXT
Immune Response to Pneumococcal Polysaccharides 4 and 14 in Elderly and Young Adults: Analysis of the Variable Heavy Chain Repertoire
Kolibab et al.
Infect. Immun. 2005;73:7465-7476.
ABSTRACT
| FULL TEXT
Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men
Smith et al.
J. Appl. Physiol. 2004;97:491-498.
ABSTRACT
| FULL TEXT
Pneumococcal Vaccination and Revaccination of Older Adults
Artz et al.
Clin. Microbiol. Rev. 2003;16:308-318.
ABSTRACT
| FULL TEXT
Acute Phase Protein Levels and Thymus, Spleen and Plasma Protein Synthesis Rates Differ in Adult and Old Rats
Papet et al.
J. Nutr. 2003;133:215-219.
ABSTRACT
| FULL TEXT
Immune Function in the Elderly
Hamer et al.
Arch Intern Med 2001;161:482-483.
FULL TEXT
|
